Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-29

Clinical Trial Update: The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration [Phase 1]

View source ↗

Summary

Phase 1 trial investigating the effects of disulfiram (Antabuse) on visual acuity in patients with retinal degeneration; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Disulfiram (Antabuse) (disulfiram)

Snippet

Sponsor: University of Rochester | Conditions: Alcohol Use Disorder, Retinal Dystrophies | Phase 1 | Status: RECRUITING